NCT00000281
Completed
Phase 2
Pharmacotherapy for Schizophrenic Drug Users
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cocaine-Related Disorders
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Retention
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Retention
Schizophrenic symptoms
Psychological symptoms
Drug use
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Customized Adherence Enhancement Plus Long-acting Injectable AntipsychoticPatient NoncomplianceNCT01152697University Hospitals Cleveland Medical Center30
Completed
Not Applicable
Treatment of Refractory Schizophrenia With RiluzoleSchizophreniaSchizoaffectiveNCT00375050Yale University34
Completed
Not Applicable
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way PagersSchizophreniaNCT00392236Northwell Health55
Completed
Not Applicable
Alcohol Use Disorders in SchizophreniaSchizophreniaMood DisordersAlcohol AbuseAlcohol DependenceNCT00280813University of Maryland, Baltimore54
Completed
Phase 4
Optimization of Treatment and Management of Schizophrenia in EuropeSchizophreniaSchizophreniform DisorderSchizoaffective DisorderNCT01248195Rene Kahn479